Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
labisia pumila + eurycoma longifolia
- Development stage
- Unknown
- Lead developer
- Biotropics Malaysia
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Nu-femme is a standardized herbal combination supplement developed by Biotropics Malaysia Berhad, consisting of water extracts from *Labisia pumila* (marketed as SLP+®) and *Eurycoma longifolia* (marketed as Physta®). *Labisia pumila*, known as Kacip Fatimah, contains flavonoids and phenolic compounds (notably gallic acid) and exhibits phytoestrogenic properties. *Eurycoma longifolia*, known as Tongkat Ali, contains quassinoids like eurycomanone and peptides that influence testosterone production. The combination is primarily indicated for the management of peri-menopausal and menopausal symptoms, including hot flushes, by balancing hormonal levels in women.
- Brand names
- Nu-femme
- Other names
- SLP+ + PhystaKacip Fatimah + Tongkat AliLabisia pumila and Eurycoma longifolia extract
02
Targets
ER (Estrogen receptor)
Beyond the preview
Go deeper on labisia pumila + eurycoma longifolia.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on labisia pumila + eurycoma longifolia.